PLUR
Pluri Inc
NASDAQ · Biotechnology
$3.47
-0.18 (-4.93%)
Open$3.72
Previous Close$3.65
Day High$3.72
Day Low$3.43
52W High$34.74
52W Low$21.31
Volume—
Avg Volume761.4K
Market Cap32.11M
P/E Ratio41.99
EPS$0.77
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,124.2% upside
Current
$3.47
$3.47
Target
$42.48
$42.48
$23.35
$42.48 avg
$52.53
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.78M | 4.21M | 5.36M |
| Net Income | -89,322 | -76,163 | -75,826 |
| Profit Margin | -1.9% | -1.8% | -1.4% |
| EBITDA | -95,763 | -73,642 | -95,229 |
| Free Cash Flow | -44,479 | -41,548 | -57,067 |
| Rev Growth | +18.6% | +17.4% | +13.4% |
| Debt/Equity | 0.96 | 0.83 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |